What is the current Aeterna Zentaris market capitalization?
The current market capitalization of Aeterna Zentaris is 5.3 M USD.
Aeterna Zentaris Market capitalization 2024
Aeterna Zentaris Market capitalization
5.3 M USD
Ticker
AEZS.TO
ISIN
CA0079754028
WKN
A1439Z
In 2024, Aeterna Zentaris's market cap stood at 5.3 M USD, a -62.83% increase from the 14.27 M USD market cap in the previous year.
The Aeterna Zentaris Market capitalization history
| YEAR | REVENUE (undefined USD) | GROSS MARGIN (%) | NET INCOME (undefined USD) |
|---|---|---|---|
| 2025e | 8.15 | 52,49 | -1.64 |
| 2024e | 4.39 | 97,49 | -10.52 |
| 2023 | 4.5 | 95,06 | -16.55 |
| 2022 | 5.6 | 98,21 | -22.7 |
| 2021 | 5.3 | 98,11 | -8.4 |
| 2020 | 3.7 | 35,14 | -5.1 |
| 2019 | 0.5 | 20,00 | -6 |
| 2018 | 26.9 | 92,19 | 4.2 |
| 2017 | 0.9 | 475,11 | -16.8 |
| 2016 | 0.9 | 475,11 | -25 |
| 2015 | 0.5 | 100,00 | -50.1 |
| 2014 | - | - | -16.6 |
| 2013 | 6.2 | 98,39 | 6.8 |
| 2012 | 2.1 | 71,43 | -20.4 |
| 2011 | 4.7 | 95,74 | -27.1 |
| 2010 | 27.7 | 32,49 | -28.5 |
| 2009 | 63.2 | 73,89 | -24.7 |
| 2008 | 38.5 | 49,87 | -59.8 |
| 2007 | 41.3 | 68,77 | -33.1 |
| 2006 | 38.8 | 70,88 | 33.4 |
| 2005 | 44.8 | 81,70 | 10.6 |
| 2004 | 33 | 81,52 | -3.4 |
Aeterna Zentaris Aktienanalyse
What does Aeterna Zentaris do?
Aeterna Zentaris Inc. is a Canadian company that has been operating in the pharmaceutical industry since 1991. The company is headquartered in Quebec City, Canada and focuses on the development and commercialization of drugs for the treatment of cancer and hormonal disorders. The company started as a small biotech company called "Aeterna Laboratories" that focused on the research of growth hormones and hormonal disorders. In the late 90s, it merged with a German company called "Zentaris GmbH" that specialized in medical diagnostics and chemicals, creating Aeterna Zentaris AG, which was later renamed Aeterna Zentaris Inc. The company has acquired several companies and expanded its portfolio of drugs and treatment options. Aeterna Zentaris is a biopharmaceutical company engaged in preclinical and clinical development of therapeutics. The company's main strategy is to develop and promote innovative and differentiating drug candidates. It works closely with leading academic institutions, researchers, and other companies to advance the development of its products. Aeterna Zentaris has a diversified portfolio of drug candidates in various stages of clinical development. It has two main divisions: cancer treatment and hormonal disorders. The company focuses on developing cancer therapeutics for various types of cancers and also on the treatment of hormonal disorders, including diabetes, growth problems, hormonally related cancers, and menopause. Some of the company's important products include Macrilen, which is used for diagnosing growth hormone deficiency, Zoptrex, which is intended for the treatment of endometrial cancer, and Perifosine, a drug candidate for advanced colorectal cancer. Aeterna Zentaris has established itself as a leading biotech company in the field of cancer and hormone therapy. It has a diverse portfolio of drug candidates in different stages of clinical development. The company collaborates with researchers, medical institutions, and other companies to develop innovative and differentiating drug candidates. Aeterna Zentaris ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring Aeterna Zentaris's Market Capitalization
Aeterna Zentaris's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Aeterna Zentaris's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Aeterna Zentaris's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Aeterna Zentaris’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Aeterna Zentaris stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Aeterna Zentaris.
How has the market capitalization of Aeterna Zentaris developed in recent years?
The market capitalization of Aeterna Zentaris has increased/decreased by -62.83% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Aeterna Zentaris?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Aeterna Zentaris?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Aeterna Zentaris have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Aeterna Zentaris pay?
Over the past 12 months, Aeterna Zentaris paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Aeterna Zentaris is expected to pay a dividend of 0 USD.
What is the dividend yield of Aeterna Zentaris?
The current dividend yield of Aeterna Zentaris is .
When does Aeterna Zentaris pay dividends?
Aeterna Zentaris pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Aeterna Zentaris?
Aeterna Zentaris paid dividends every year for the past 0 years.
What is the dividend of Aeterna Zentaris?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Aeterna Zentaris located?
Aeterna Zentaris is assigned to the 'Health' sector.
Wann musste ich die Aktien von Aeterna Zentaris kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Aeterna Zentaris from 7/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/4/2024.
When did Aeterna Zentaris pay the last dividend?
The last dividend was paid out on 7/4/2024.
What was the dividend of Aeterna Zentaris in the year 2023?
In the year 2023, Aeterna Zentaris distributed 0 USD as dividends.
In which currency does Aeterna Zentaris pay out the dividend?
The dividends of Aeterna Zentaris are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Aeterna Zentaris stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Aeterna Zentaris
Our stock analysis for Aeterna Zentaris Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aeterna Zentaris Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Aeterna Zentaris Revenue
- Aeterna Zentaris Net Income
- Aeterna Zentaris P/E
- Aeterna Zentaris P/S
- Aeterna Zentaris EBIT
- Aeterna Zentaris Dividend
- Aeterna Zentaris Stocks
- Aeterna Zentaris Market capitalization
- Aeterna Zentaris Debt
- Aeterna Zentaris Liabilities
- Aeterna Zentaris Equity
- Aeterna Zentaris AAQS
- Aeterna Zentaris Employees
- Aeterna Zentaris ROE
- Aeterna Zentaris ROA
- Aeterna Zentaris ROCE
